Inari Medical Dividend 2024

Dividend Details

Understanding Inari Medical's Dividend Distributions

Inari Medical’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Inari Medical's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Inari Medical's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Inari Medical’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Inari Medical Aktienanalyse

What does Inari Medical do?

Inari Medical Inc. is an American medical technology company founded in 2013 and headquartered in Irvine, California. The company specializes in the development and manufacturing of medical devices for the treatment of vascular diseases. The founders of Inari Medical are Vinayak "Vin" P. Kasabwala and Dr. Thomas "Thom" C. Fogarty. Dr. Fogarty is a well-known pioneer in the field of minimally invasive surgery and has filed more than 160 patents. Both founders have an impressive track record in the development and marketing of medical technology products. Inari Medical's business model is based on the development and marketing of products for the minimally invasive treatment of vascular diseases. The company's goal is to develop medical devices that improve the treatment of these diseases and allow patients to recover faster. Inari Medical is divided into various business units, each specializing in the treatment of different types of vascular diseases. The "VENA" business unit focuses on the treatment of vein diseases such as deep vein thrombosis or blockages of larger veins. The "TROMBUS" business unit is dedicated to the treatment of blood clots in the veins that can be life-threatening. Inari Medical's portfolio includes various medical devices that can be used for this purpose. These include catheters that use ultrasound waves to destroy blood clots without damaging the surrounding tissue. The "PULMUS" business unit specializes in the treatment of pulmonary embolisms, which are blockages of the lung arteries caused by a blood clot. Pulmonary embolisms can be life-threatening and require immediate treatment. Inari Medical Inc. has various products on the market that can be used for the treatment of vascular diseases. These include the ClotTriever thrombectomy catheter, the ClotTriever system, and the FlowTriever system. These products enable fast and effective treatment of vein diseases, blood clots, and pulmonary embolisms. The ClotTriever system is a specially designed catheter that removes compact blood clots that form in the veins and large blood vessels. A special filter system is used to prevent the blood clot from entering other parts of the body. The FlowTriever system, on the other hand, is used for the treatment of pulmonary embolisms. A special catheter is inserted into the pulmonary artery to remove the blood clot and restore blood flow to the lungs. The FlowTriever system is designed to quickly and effectively remove the blood clot without damaging the surrounding tissue. Inari Medical aims to revolutionize the treatment of vascular diseases and enable patients to recover faster. The company has an impressive track record in the development and marketing of medical devices and will continue to offer innovative solutions for the treatment of vascular diseases in the future. Inari Medical is one of the most popular companies on Eulerpool.com.

Frequently Asked Questions about Inari Medical stock

How much dividend does Inari Medical pay?

Over the past 12 months, Inari Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Inari Medical is expected to pay a dividend of 0 USD.

What is the dividend yield of Inari Medical?

The current dividend yield of Inari Medical is .

When does Inari Medical pay dividends?

Inari Medical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Inari Medical?

Inari Medical paid dividends every year for the past 0 years.

What is the dividend of Inari Medical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Inari Medical located?

Inari Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Inari Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Inari Medical from 11/6/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/6/2024.

When did Inari Medical pay the last dividend?

The last dividend was paid out on 11/6/2024.

What was the dividend of Inari Medical in the year 2023?

In the year 2023, Inari Medical distributed 0 USD as dividends.

In which currency does Inari Medical pay out the dividend?

The dividends of Inari Medical are distributed in USD.